BIRZNIEKS GUNTHER (SVP, Business Development) reported 1 transaction at VANDA PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/4/2025ACC: 0000950170-25-032281
Officer· SVP, Business Development
Since Mar 2026
-26.94K
Net shares
Net seller
$128.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
26.94K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−26.94K
Price / share
$4.76
Trade value
$128.24K
% of position
6.1%
3/1/2025
438.57K→411.63K
Total
Net shares
−26.94K
Net value
-$128.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | F · Tax Withholding | −26.94K | $4.76 | $128.24K | 6.1% | 438.57K | 411.63K |
| Total | −26.94K | -$128.24K | ||||||
Derivative Transactions0
No derivative transactions reported